Subtle Medical Secures Phase II Funding for Brain Imaging Tech
![Subtle Medical Secures Phase II Funding for Brain Imaging Tech](https://investorshangout.com/images/blog/ihnews-Subtle%20Medical%20Secures%20Phase%20II%20Funding%20for%20Brain%20Imaging%20Tech.jpg)
Subtle Medical Awarded Phase II Funding for SubtleSYNTH™ Expansion
The news comes on the heels of SubtleSYNTH receiving FDA clearance of SubtleSYNTH™ for Spine STIRs.
Subtle Medical, an innovative leader in AI-powered medical imaging solutions, has been granted Phase II funding under the NIH SBIR grant to further develop its groundbreaking SubtleSYNTH™ technology. This latest phase aims to extend the capabilities of SubtleSYNTH™ specifically to brain imaging, capitalizing on its prior success in generating synthetic STIR images for spinal imaging.
Significant Milestone in Medical Imaging
SubtleSYNTH™ recently achieved an important milestone by obtaining FDA clearance for the generation of synthetic STIR images (SynthSTIRs) derived from existing T1 and T2 weighted contrasts in spinal imaging. This clearance is a pivotal advancement in MRI technology, providing zero acquisition time for SynthSTIRs while maintaining clinical quality on par with traditional STIR images. SubtleSYNTH™ is a vital part of Subtle Medical's expanding suite of AI-driven solutions, which also includes the FDA-cleared SubtleMR™ and SubtlePET™ software.
Enhancing MRI Efficiency
The Phase II SBIR grant will facilitate the expansion of SubtleSYNTH™ into brain imaging, tackling a notable unmet need in this field. By utilizing deep learning techniques to produce high-quality synthetic images without the demand for additional scanning time, SubtleSYNTH™ aims to enhance the efficiency and accuracy of MRI procedures. This advancement promises benefits for both patients and imaging institutions facing challenges such as procedure backlogs and extended wait times.
Ajit Shankaranarayanan, Chief Product Officer at Subtle Medical, expressed the company's enthusiasm for this funding. "We are thrilled to secure Phase II funding for the advancement of our SubtleSYNTH™ technology. This grant underscores the scientific merit of our work and enables us to expand the horizons of medical imaging. With our FDA clearance for spine imaging and the backing of NIH, we are poised to introduce this revolutionary technology into brain imaging, amplifying the speed, quality, and safety of MRI examinations."
Commitment to Innovation in Medical Imaging
Subtle Medical's SubtleSYNTH™ technology has gained recognition for its potential to transform MRI imaging by cutting down scan times and boosting workflow efficiency. The recent FDA clearance for spine STIRs, coupled with the new Phase II SBIR grant funding, reinforces the company's commitment to advancing medical imaging through innovative AI solutions.
About Subtle Medical
Subtle Medical is a prominent global contender in AI-driven technology dedicated to faster, safer, and more efficient medical imaging. The company's advanced imaging solutions enhance radiological workflows, enhancing productivity and patient experiences. Recognized as a CB Insights GenAI 50 company, Subtle Medical has also appeared on the CB Insights Top AI 100 and Digital Health 150 lists on numerous occasions. By leveraging artificial intelligence, Subtle Medical is molding the future landscape of healthcare.
For more information, please visit subtlemedical.com or reach out via email at [email protected].
Frequently Asked Questions
What is Subtle Medical's recent achievement?
Subtle Medical has received Phase II funding for its NIH SBIR grant to expand its SubtleSYNTH™ technology into brain imaging.
What technology does SubtleSYNTH™ offer?
SubtleSYNTH™ provides AI-generated synthetic STIR images, allowing for improved MRI efficiency and quality without additional scan time.
How does the Phase II funding benefit Subtle Medical?
This funding allows Subtle Medical to advance its SubtleSYNTH™ technology for brain imaging, addressing significant needs in medical imaging.
Who is the Chief Product Officer of Subtle Medical?
Ajit Shankaranarayanan serves as the Chief Product Officer at Subtle Medical.
Where can I find more information about Subtle Medical?
More information about Subtle Medical and its innovations can be found on their website at subtlemedical.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Expert Insights Unveiled for RBQMLive 2024 Event Success
- Vaseline® Launches Pro Vitab3 Serum-Burst Lotion for Skin Care
- Big Wave Systems Partners with CMS for Health Insurance Support
- NKF Launches Essential Online Education for Kidney Disease
- Whitney Economics Lowers Hemp Acreage Forecast Significantly
- Flexential's Innovative Growth Strategies Set for 2024 Success
- Vanguard Lowers Asset Minimums for Enhanced Digital Advice
- Saudi Arabia's Stock Market Overview: Tadawul Performance Insights
- Global Market Index Sees Declining Returns for Investors
- Catchlight Launches Beta for Innovative Lead Routing Model
- Automated Liquid Handling Technologies Set for Major Growth
- Cinnamon-Based Solution: A Game Changer for Wound Care
- Innovative FlashBang System Launch by Deep Sentinel for Businesses
- Bad Ass Coffee of Hawaii Expands with New Jersey Franchise Deal
- Aurigo Software Enhances Right of Way Solutions for Agencies
- Plex Revolutionizes Movie Rentals for Canadian Streamers
- Wearable Devices Innovates Gesture Control with Neural Tech
- Summit Ridge Energy Partners with Siemens for Domestic Inverters
- Battery Coating Market Forecast: Growth to USD 1130 Million
- NeoVolta Secures $5 Million Credit, Enhances Financial Strength
- Doré Copper Launches $4.62M Private Placement for Growth
- Byrna Technologies Reports Remarkable Growth in Q3 2024
- LIXTE Secures U.S. Patent for Innovative Cancer Treatments
- SeaStar Medical Eliminates Long-Term Debt to Enhance Growth
- Central Florida Hospital Integrates Daxor’s BVA-100™ for Care
Recent Articles
- NKF Launches Essential Online Education for Kidney Disease
- SSI Raises $1 Billion to Develop Advanced AI Safety Solutions
- LIXTE Secures U.S. Patent for Innovative Cancer Treatments
- Fortress Biotech's Upcoming Presentation at Global Conference
- BiomX CEO to Showcase Innovations at Investment Conference
- APA Infrastructure Announces Cash Tender Offer for Senior Notes
- Survey Reveals AI is Key Focus for Healthcare Leaders
- Saia Reports Impressive Third Quarter LTL Performance Data
- Cardano vs. Polkadot: Who Will Dominate Blockchain Governance?
- Mobilicom Launches Innovative 8-Inch Ground Control Station
- Farm Equipment Market Growth Projections Through 2032
- BioVaxys to Showcase Innovative Cancer Vaccination Data Soon
- AlphaGraphics Recognized Among 2024's Most Profitable Franchises
- Kimco Realty Upsizes Term Loan Facility to $550 Million
- TSMC and Samsung's Positive AI Outlook at Trade Show
- Intel Faces Challenges with Broadcom Amid Manufacturing Setbacks
- PAM Health Announces Strategic Promotions for Growth
- Way.com Teams Up with Sea Air FCU for Affordable Auto Loans
- Roundhill Investments Announces XDTE and QDTE ETF Distributions
- Dalata Hotel Group Reports Lower Earnings, Shares Drop 4.4%
- Star Entertainment Faces Challenges While Finalizing Results
- Digital Neuro Biomarkers Market Set for Major Growth by 2033
- MidWestOne Bank Enhances Digital Onboarding Experience
- KKR's Tender Offer for Fuji Soft Set to Launch Soon
- Body Mist Market Set to Achieve USD 12.6 Billion by 2033